首页 > 最新文献

The Canadian journal of oncology最新文献

英文 中文
Health-related quality of life: measurement and clinical application. A workshop report. 健康相关生活质量:测量和临床应用。研讨会报告。
Pub Date : 1995-03-01
D Osoba, J E Till, J L Pater, J R Young

The process of measuring health-related quality of life (HQL) in oncology is reviewed and the role of these results in clinical practice and clinical trials is discussed. It is determined that comparisons of HQL measurement instruments are needed to clarify which questionnaires are preferable in particular populations or situations. "Calibration" data are also needed, to help explain the meaning of HQL scores and to link them to external reality. In phase III clinical trials, HQL assessment is most important in trials involving disease sites and stages with a poor prognosis and when comparing treatments not expected to affect survival.

综述了肿瘤学中健康相关生活质量(HQL)的测量过程,并讨论了这些结果在临床实践和临床试验中的作用。确定需要对HQL测量工具进行比较,以澄清在特定人群或情况下哪种问卷更可取。还需要“校准”数据,以帮助解释HQL分数的含义,并将其与外部现实联系起来。在III期临床试验中,在涉及疾病部位和分期、预后较差的试验中,以及在比较预计不会影响生存的治疗方法时,HQL评估最为重要。
{"title":"Health-related quality of life: measurement and clinical application. A workshop report.","authors":"D Osoba,&nbsp;J E Till,&nbsp;J L Pater,&nbsp;J R Young","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The process of measuring health-related quality of life (HQL) in oncology is reviewed and the role of these results in clinical practice and clinical trials is discussed. It is determined that comparisons of HQL measurement instruments are needed to clarify which questionnaires are preferable in particular populations or situations. \"Calibration\" data are also needed, to help explain the meaning of HQL scores and to link them to external reality. In phase III clinical trials, HQL assessment is most important in trials involving disease sites and stages with a poor prognosis and when comparing treatments not expected to affect survival.</p>","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"5 1","pages":"338-43"},"PeriodicalIF":0.0,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19820576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of using a prognostic index to select therapy for patients with aggressive histology lymphoma. 应用预后指标选择侵袭性组织学淋巴瘤治疗的意义。
Pub Date : 1995-03-01
R M Meyer, G P Browman

The International Non-Hodgkin's Lymphoma Prognostic Factor Index (INHLPF-Index) is a validated method of determining prognosis for patients with aggressive histology lymphoma and is now being used to identify those who might benefit most from new investigative therapies. This review assesses its usefulness and potential clinical utility in this context, and shows that several factors will determine the clinical utility of using this index, including the inherent accuracy of the index, the effect of mislabelling and the efficacy and toxicity of experimental treatment.

国际非霍奇金淋巴瘤预后因子指数(INHLPF-Index)是一种确定侵袭性组织学淋巴瘤患者预后的有效方法,目前被用于确定那些可能从新的调查性治疗中获益最多的患者。这篇综述评估了它在这种情况下的有用性和潜在的临床应用,并表明几个因素将决定使用该指数的临床应用,包括指数的固有准确性、错误标记的影响以及实验治疗的疗效和毒性。
{"title":"Implications of using a prognostic index to select therapy for patients with aggressive histology lymphoma.","authors":"R M Meyer,&nbsp;G P Browman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The International Non-Hodgkin's Lymphoma Prognostic Factor Index (INHLPF-Index) is a validated method of determining prognosis for patients with aggressive histology lymphoma and is now being used to identify those who might benefit most from new investigative therapies. This review assesses its usefulness and potential clinical utility in this context, and shows that several factors will determine the clinical utility of using this index, including the inherent accuracy of the index, the effect of mislabelling and the efficacy and toxicity of experimental treatment.</p>","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"5 1","pages":"344-54"},"PeriodicalIF":0.0,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19820577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restructuring: meeting the challenges. 重组:迎接挑战。
Pub Date : 1995-03-01
J D Beatty
{"title":"Restructuring: meeting the challenges.","authors":"J D Beatty","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"5 1","pages":"VII-IX"},"PeriodicalIF":0.0,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19821272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issues for interpreting external stakeholder feedback on restructuring NCIC's research programs. 解释外部利益相关者对NCIC研究项目重组反馈的问题。
Pub Date : 1995-03-01
F D Ashbury, D C Iverson, P J Shephard

The National Cancer Institute of Canada surveyed members of its stakeholder groups on a number of issues pertaining to restructuring research programs. While it was hoped that the survey would ensure input from its primary stakeholder groups and thereby facilitate decision-making on critical issues like distribution of funds and research awards, there is reason to believe this may not have occurred. Some of the stakeholder groups seemed to be over-represented in the respondent population and the effect of this on the results was therefore examined. Analysis revealed several important issues: 1) a clear definition of who constitutes a "stakeholder" needs to be developed when stakeholder input-gathering is being contemplated; 2) multi-faceted strategies need to be developed to gain input from stakeholders; 3) potential sources of bias can emerge from the various techniques used to gather feedback from stakeholders; and 4) a clear outline of how the feedback is to be used in the decision-making process needs to be determined.

加拿大国家癌症研究所调查了其利益相关者团体的成员关于重组研究项目的一些问题。虽然人们希望这项调查能确保主要利益相关者群体的投入,从而促进在资金分配和研究奖励等关键问题上的决策,但有理由相信这可能没有发生。一些利益相关者群体在被调查者中似乎代表过多,因此对这对结果的影响进行了检查。分析揭示了几个重要问题:1)在考虑收集利益相关者的意见时,需要明确定义谁是“利益相关者”;2)需要制定多方面的战略,以获得利益相关者的投入;3)从利益相关者那里收集反馈的各种技术可能会产生潜在的偏见来源;4)需要确定如何在决策过程中使用反馈的清晰大纲。
{"title":"Issues for interpreting external stakeholder feedback on restructuring NCIC's research programs.","authors":"F D Ashbury,&nbsp;D C Iverson,&nbsp;P J Shephard","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The National Cancer Institute of Canada surveyed members of its stakeholder groups on a number of issues pertaining to restructuring research programs. While it was hoped that the survey would ensure input from its primary stakeholder groups and thereby facilitate decision-making on critical issues like distribution of funds and research awards, there is reason to believe this may not have occurred. Some of the stakeholder groups seemed to be over-represented in the respondent population and the effect of this on the results was therefore examined. Analysis revealed several important issues: 1) a clear definition of who constitutes a \"stakeholder\" needs to be developed when stakeholder input-gathering is being contemplated; 2) multi-faceted strategies need to be developed to gain input from stakeholders; 3) potential sources of bias can emerge from the various techniques used to gather feedback from stakeholders; and 4) a clear outline of how the feedback is to be used in the decision-making process needs to be determined.</p>","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"5 1","pages":"328-37"},"PeriodicalIF":0.0,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19820575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NCIC perspective on cancer control. NCIC对癌症控制的看法。
Pub Date : 1994-11-01
J D Beatty
{"title":"NCIC perspective on cancer control.","authors":"J D Beatty","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"2-3"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19820578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life and prostate cancer treatment: decision-making and rehabilitative support. 生活质量与前列腺癌治疗:决策和康复支持。
Pub Date : 1994-11-01
P G Ritvo
{"title":"Quality of life and prostate cancer treatment: decision-making and rehabilitative support.","authors":"P G Ritvo","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"43-5; discussion 46"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19820589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The European Screening Study for Prostate Cancer. 欧洲前列腺癌筛查研究。
Pub Date : 1994-11-01
F H Schröder
{"title":"The European Screening Study for Prostate Cancer.","authors":"F H Schröder","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"102-5; discussion 106-9"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19822411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What studies should be undertaken in Canada to determine the value of screening for prostate cancer? 加拿大应该进行哪些研究来确定前列腺癌筛查的价值?
Pub Date : 1994-11-01
{"title":"What studies should be undertaken in Canada to determine the value of screening for prostate cancer?","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"119-24"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19822413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The need to measure quality of life in a prostate cancer screening trial. 在前列腺癌筛查试验中测量生活质量的必要性。
Pub Date : 1994-11-01
D Iverson
{"title":"The need to measure quality of life in a prostate cancer screening trial.","authors":"D Iverson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"76-7"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19822406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommendations from the BC Office of Health Technology Assessment. 不列颠哥伦比亚省卫生技术评估办公室的建议。
Pub Date : 1994-11-01
K Bassett

The BCOHTA does not make recommendations or set policy; rather, we report on the evidence. Our message is clear: For asymptomatic men, there is no evidence that annual or semi-annual PSA testing will do any good. There is substantial evidence that PSA testing will lead to considerable harm.

BCOHTA不提出建议或制定政策;相反,我们报告的是证据。我们的信息很明确:对于无症状的男性,没有证据表明每年或半年一次的PSA检测会有任何好处。有大量证据表明,PSA检测将导致相当大的危害。
{"title":"Recommendations from the BC Office of Health Technology Assessment.","authors":"K Bassett","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The BCOHTA does not make recommendations or set policy; rather, we report on the evidence. Our message is clear: For asymptomatic men, there is no evidence that annual or semi-annual PSA testing will do any good. There is substantial evidence that PSA testing will lead to considerable harm.</p>","PeriodicalId":79379,"journal":{"name":"The Canadian journal of oncology","volume":"4 Suppl 1 ","pages":"86-8; discussion 89-95"},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19822409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Canadian journal of oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1